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ABSTRACT
Background: Severe malnutrition contributes up to 50% of childhood mortality in 
developing countries  is frequently characterised by electrolyte depletion, including 
low total body phosphate. During therapeutic re-feeding, electrolyte shift from extra-
cellular to intra-cellular compartments may induce hypo-phosphataemia (hypo-P) 
with resultant increased morbidity and mortality. This biochemical imbalance is 
under-recognised, and the frequency of this problem among African malnourished 
children is unclear. 
Objectives: To determine the magnitude of hypo-phosphataemia in children under 
five years of age presenting to Kenyatta National Hospital with kwashiorkor and 
marasmic kwashiorkor and to evaluate the relationship between hypo- phosphataemia 
and nutritional intervention during the first five days of treatment. 
Design: Short longitudinal survey. 
Setting: The General Paediatric wards of the Kenyatta National Hospital (KNH), 
Nairobi. 
Subjects: Children under five years of age presenting with kwashiorkor or marasmic 
kwashiorkor at KNH were recruited into the study. 
Main outcome measures: Low serum phosphate level (<1.20mmol/l) and patient outcome 
(survival or death) during the first five days of treatment. 
Results: One hundred and sixty five children were enrolled between June 2005 and 
February 2006 of which 107 (64%) had kwashiorkor and 58 (36%) had marasmic 
kwashiorkor. They were of mean age 20 months (range 3-60), and 95 (58%) were male. 
The prevalence of hypo-phosphataemia was 86% on admission, increased to 90% and 
93% on day one and two respectively, and then declined to 90% by the fourth day. 
At admission 6% were hypo-phosphataemic, increasing to 18% and 22% on day one 
and two respectively, and declining to 11% by day four. On admission mean serum 
phosphate was below normal at 0.91mmol/l, declined significantly to 0.67mmol/l and 
to a nadir of 0.63mmol/l after the first and second day of treatment respectively, then 
rose slightly to 0.75mmol/l on the fourth day (p<0.001 comparing each follow-up mean 
level with the admission level). There was a positive association between severity of 
nadir serum phosphate level and mortality (p=0.028). There were no deaths among 
children with normal nadir serum phosphate levels. However, among children with 
mild, moderate and severe nadir hypo-phosphataemia, 8, 14 and 21% died respectively. 
Children with dermatosis and hypomagnesaemia showed a trend for association with 
mortality (p=0.082 and 0.099 respectively). 
Conclusion: Hypo-phosphataemia is frequent among children with kwashiorkor 
and marasmic kwashiorkor presenting at KNH. Serum phosphate levels decline 
significantly during the first two days of nutritional intervention, and severity of 
hypo-phosphataemia is directly associated with mortality.
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INTRODUCTION
Nutritional deficiencies constitute a major public 
health problem in the tropical and subtropical 
regions of the world. Among them, protein energy 
malnutrition (PEM) is the most widespread condition. 
In Africa, the estimated prevalence of severe PEM 
ranges between 1.7 -9.8% (1). According to the Kenya 
Demographic Health Survey (KDHS) of 2003, 20% of 
children below five years of age were underweight 
and 4% were severely underweight (2). 
 Despite improved medical care, mortality of 
children with severe PEM remains high at 10-20% (3). 
Mortality in kwashiorkor is reported by Fechner et al 
(4) to range between 10 and 50%. This high mortality 
is mainly found in sub-Saharan Africa despite 
implementation of standard treatment protocols (5). 
Observations from the Paediatric Emergency Ward 
at KNH showed that malnutrition accounted for 7% 
of admissions and 15% of mortality (6). 
 A number of biochemical changes in the 
blood and tissues have been described in PEM (1). 
The most common electrolyte abnormalities are 
hypo-phosphataemia (hypo-P), hypokalaemia and 
hypomagnesaemia, and they have been associated 
with mortality in the initial days of treatment (7,8). 
Phosphorus is an essential macro-mineral generally 
found in the human body as part of the phosphate 
anion, 80% of which is intra-cellular and principally 
found in bones. The phosphate,  ion is involved in the 
energy pathways of the cell. Although it is available in 
most foods, it tends to be depleted in certain disease 
states like malnutrition. 
 Hypo-phosphataemia has become a topic of 
concern due to increasing evidence that it may be 
associated with serious morbidity (9). Hypo-P has been 
found in patients being therapeutically re-fed after 
severe weight loss (9). Re-feeding syndrome is defined 
as the occurrence of severe fluid and electrolytes shifts 
and their associated complications in malnourished 
patients undergoing enteral or parenteral re-feeding 
(10,11). The main abnormalities observed include 
hypo-P, hypokalaemia and hypomagnesaemia (10,11). 
Re-feeding syndrome is one of the few conditions 
associated with profound hypo-P due to intra-cellular 
shifts of phosphorus (9). It is known that malnourished 
children are depleted of phosphorus due to renal loss 
and inadequate intake during starvation. During re-
feeding, there is a sudden introduction of carbohydrate 
which stimulates insulin release. Insulin subsequently 
increases cellular uptake of glucose, phosphate and 
water into cells and this results in a severe hypo-P, a 
central component of the re-feeding syndrome. 
 Re-feeding syndrome is associated with high 
mortality. Patients at risk include those with anorexia 
nervosa, chronic alcoholism, chronic malnutrition, 
the elderly and oncology patients. Friemen et al (12) 
found that 10% (6 of 60) of children presenting with 
kwashiorkor in South Africa had severe hypo-P 
and that the metabolic disturbance was associated 
with dehydration and death. Severe hypo-P (serum 
phosphate <0.33mmol/l), occurred in eight (12%) 
of 68 children with kwashiorkor within 48 hours 
of admission and five (63%) of the eight children 
died compared with 13 (22%) of the 60 without 
severe hypo-P (p<0.02). Therefore it was concluded 
that severe hypo-P seems to be common and life 
threatening in children with kwashiorkor (13). In 
the same study, dermatosis and dehydration were 
significantly correlated with severe hypo-P but 
these clinical signs could not reliably predict fatal 
outcomes. 
 A systematic review of literature revealed 27 
children that developed re-feeding syndrome after 
oral or enteral feeding, nine (33%) of whom died as a 
direct result of complications of this syndrome (10). 
Cautious progressive nutrition rehabilitation and 
careful monitoring of vital signs, electrolyte levels 
and fluid balance are essential for prevention of 
morbidity and mortality from this syndrome (14). 
 It was with this background that we determined 
to evaluate the magnitude of hypo-P among children 
under five years of age admitted to KNH with 
kwashiorkor or marasmic kwashiorkor, and to 
evaluate association between hypo-P and outcome 
during the first five days of treatment. 
MATERIALS AND METHODS
This was a short longitudinal survey between June 
2005 and February 2006 at KNH, a teaching and 
referral hospital in Nairobi, Kenya. All children 
under five years of age admitted to the hospital with 
kwashiorkor or marasmic kwashiorkor during the 
study period, whose mothers/guardians consented, 
were eligible for inclusion. Patients were excluded 
if they had rickets, diabetes mellitus or if they were 
on antacid, diuretic or insulin therapy.
 Outcomes of interest included prevalence and 
severity of hypo-P, and survival versus death during 
five day follow up. Approval to carry out the study 
was obtained from the KNH Ethics and Research 
Committee. 
Clinical and laboratory procedures: The investigator 
visited the study area daily from 8.00 am to 5.00 
pm and consecutively enrolled subjects meeting the 
inclusion criteria and consenting to participate until 
the desired sample size was achieved. The initial 
evaluation included a complete history and physical 
examination. Demographic and clinical data of each 
subject were obtained and recorded.
 Subjects were classified according to the 
Welcome Trust classification as kwashiorkor if they 
had oedema and weight for age fell between 60 to 
80% of expected; they were classified as marasmic 
kwashiorkor if they had oedema and their weight 
for age was less than 60% of expected.
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 During this initial contact, 2 millilitres of blood 
was collected, placed in a labelled plain plastic 
container and promptly transported to the Renal Unit 
laboratory within the hospital for analysis. Blood 
sampling was done serially at admission (day 0), and 
on days one, two and four after admission. 
Patients follow-up: In the wards, patients were 
managed for malnutrition by the ward clinicians 
according to hospital guidelines. This entailed the 
use of special milk which is a mixture of cow’s milk, 
sugar, corn oil and eggs that contains approximately 
100 Kcal/dl when ingested. The starting volumes 
usually were 100mls/kg/day divided into eight 
equal three hourly feeds. Infections and other co-
morbidities were managed routinely following 
the usual hospital guidelines. The patients were 
reviewed every morning for up to seven days and 
outcome recorded as either ‘alive’ or ‘died’ at one 
week post-admission. For those who died, the time 
from admission to death was recorded.
Laboratory investigations: Serum was separated 
within two hours to avoid haemolysis and thereafter 
biochemical analysis performed using the automated 
method. Baseline serum phosphorus, albumin, 
magnesium and calcium were determined. Serum 
phosphorus was subsequently assayed on days one, 
two and four post-admission. 
Data management: Data were managed using the 
Statistical Package for Social Sciences Software (SPSS 
version 11). The prevalence of hypo-P was determined 
and categorised into normal phosphate (1.20-
2.30mmol/l), or mild (0.80-1.19mmol/1), moderate 
(0.3-30.79mmol/l) and severe hypo-P (<0.33mmol/1). 
The lowest ever serum phosphate level reached (nadir 
phosphate) was computed for all the children and the 
day on which the nadir occurred noted. The mean 
serum phosphate level was calculated among children 
who died and in those that survived on each day and 
compared using independent t-test. 
 Continuous variables were compared using 
students t-test, and categorical values were compared 
using Chi-square test, Fisher’s Exact test and Chi-
square for linear trends as appropriate. Level of 
significance was set at <0.05. 
RESULTS
Description of the cohort:  Out of 165 children enrolled 
into the study between June 2005 and February 
2006, 107 (64%) had kwashiorkor and 58 (36%) had 
marasmic kwashiorkor. Males comprised 58% (95 of 
165) with a male to female ratio of 1.4: 1. The mean 
age of the children in the study was 20 months (range 
3-60) with mean ages of 23 months for children with 
kwashiorkor and 19 months for those with marasmic 
kwashiorkor. Common morbidities included 
dehydration in 104 (63%), diarrhoea in 93 (56%) and 
dermatosis in 62 (38%) of children (Table 1).
Prevalence and severity of hypo-phosphataemia: On the 
day of admission 142 of 165 children had hypo-P, 
giving a prevalence of 86% and of these nine (6%) had 
severe hypo-P. Prevalence of hypo-P was similarly 
high among children with kwashiorkor and those with 
marasmic kwashiorkor (89 versus 99% respectively, 
p=0.166). Among the 142 hypo-phosphataemic 
children, 90 (54%) had mild, 43 (26%) had moderate 
and nine (6%) had severe hypo-P (Table 2). 
Table 1
Demographic and clinical characteristics of  children with kwashiorkor at the Kenyatta National Hospital (n=165)
Characteristic  No. (%)
Sex Males 95  58
Age (months) Mean (Range) 20  3-60
Class of malnutrition Kwashiorkor  107  64
 Marasmic- kwashiorkor 58 36
Hydration status Dehydration 104 63
Frequency and duration of Diarrhoea 94 57
diarrhoea Acute 60 36
 Chronic 34 21
Presence of infection Yes 134 81
Presence of dermatosis Present 62 38
IV Glucose given Yes 46 28
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During nutritional intervention, the overall prevalence 
of hypo-P increased to 90% on day one, to 93% on day 
two, and dropped to 90% on day four. The prevalence 
of severe hypo-P tripled to 18% on day one, further 
increased to 22% on day two, and declined to 11% 
on day four (Table 3). 
We report on mean phosphorous levels from 
admission day to the fourth post-admission day. The 
mean serum phosphate level dropped significantly 
from baseline level of 0.91 mmol/l to 0.67 mmol/L 
and 0.63mmol/l after one and two days of treatment 
respectively (p<0.001). Phosphate levels thereafter 
rose to 0.75 mmol/l on day four (Figure 1). 
 The majority of children (47%) experienced their 
lowest serum phosphate level (nadir) on day two, 
whilst 21%, 22% and 10% experienced nadir levels 
on days zero, one and four respectively. 
Outcome following nutritional intervention: Twenty 
one (13%) children died during the first five days 
in hospital. During follow-up, we noted that the 
mean serum phosphate level on any given day was 
lower among those who died than among survivors 
although this difference did not achieve statistical 
significance (Figure 2). 
Table 2
Prevalence of hypo-phosphataemia at presentation in children with kwashiorkor presenting at Kenyatta National 
Hospital  (n=165)
Presence or absence of low Kwashiorkor  Marasmic All patients
serum phosphate  kwashiorkor 
 No.  (%) No.  (%) No.  (%)
Hypo-phosphatemia present
  Mild 57   53 33   57 90   54   
  Moderate 25   23 18   31  43   26   
  Severe  7     7 2     3 9     6   
Total hypo-phosphataemia 89   83 53   91 142  86   
Hypo-phosphataemia absent 18   17 5     9 23   14
Total 107  100 58  100  165  100
Table 3
Prevalence of hypo-phosphataemia during nutritional intervention in children with kwashiorkor at Kenyatta 
National Hospital
Presence or absence of low Day 0 Day 1 Day 2 Day 4
serum phosphate No.  (%) No.  (%) No.  (%) No.  (%)
Hypo-phosphataemia present
  Mild 90    54 45   28 44   28 52   34
  Moderate 43    26 71   44 68   43 68   45
  Severe  9     6 29   18 35    22 17   11
Total hypo-phosphataemia 142   86 145  90 147   93 137  90
Hypo-phosphataemia absent 23    14 16   10 11    7 15   10
Total 165  100 161  100 158   100 152  100
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Figure 1
Trends of mean serum phosphate level during intervention in children with kwashiorkor at Kenyatta National 
Hospital
The nadir serum phosphate level was established for 
each child and used to categorise children into either 
normal nadir serum phosphate or mild, moderate 
or severe hypophosphataemic nadir. Mortality rose 
significantly with increasing severity of nadir hypo-P 
from no deaths among children with normal serum 
nadir phosphate, to  8%, 14% and 21% mortality 
among children with mild, moderate and severe nadir 
hypo-P respectively (p = 0.028) (Figure 3).
 In univariate analysis there was a trend for 
severe hypo-P among children with versus without 
dermatosis (67% vs 36% respectively, p = 0.082) 
and among children with versus without low 
magnesium levels (78% vs 48% respectively, p = 0.099) 
at admission. There was no association however 
between malnutrition class, sex, age, hydration 
status, diarrhoea, infection, intravenous glucose 
administration, albumin, calcium and severe  hypo- P 
on admission. 
DISCUSSION
Hypo-P occurs frequently among children less than 
five years of age with kwashiorkor and marasmic 
kwashiorkor admitted to the paediatric wards of 
KNH. An overall prevalence of hypo-P of 86% at 
presentation and of severe hypo-P of 6% was observed. 
This is consistent with what has been found in other 
studies especially in Africa. Frieman et al (12) in 
South Africa found 10% of all children presenting 
with kwashiorkor to have severe hypo-P and that 
this metabolic disturbance was associated with 
dehydration and death. The overall prevalence of 
hypo-P in their study was, however, lower at 57%. 
 A fairly recent Malawian study found an overall 
prevalence of hypo-P at presentation to be high at 
76% with a prevalence of severe hypo-P of 12% which 
was positively associated with death (13).
 Similar high prevalence of 50% of hypo-P was 
observed in two studies done in the paediatric 
intensive care units (16). Commonly associated with 
hypo-P in these patients were malnutrition, re-feeding 
syndrome, sepsis, trauma, and diuretic and steroid 
therapies. The patients in the current study were all 
severely malnourished and being therapeutically 
re-fed and so the finding of a high prevalence of 
hypo-P both at presentation and during follow up 
is not surprising. 
 We speculate that the prevalence of severe 
hypo-P of 6% might not portray the true picture 
of the magnitude of severe phosphorus deficiency 
in this cohort. This is because during starvation, in 
order to maintain normal phosphate levels there is 
catabolic release of phosphate from intra-cellular 
stores which is subsequently lost in the urine and 
therefore significant total body phosphate depletion 
can occur despite normal serum phosphate levels (l5). 
Severely malnourished children most often have had 
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a long-term relatively low phosphate intake which 
predisposes them to significant total body phosphate 
depletion (9,16).
 Up to 86% of our patients already had hypo-P 
on admission and hence it is not surprising to see 
a progression to severe hypo-P with nutritional 
repletion. Afzal et al (10) reported 27 children 
(<18 years) that developed re- feeding syndrome 
characterised by a fall in phosphate after enteral 
feeding with high calorie feeds. In general, these 
children were malnourished (weight range 45-75% 
of ideal weight for height) with seven of them having 
kwashiorkor . The cohort in our study comprised 
severely malnourished children with a weight for 
age below 80% who were similarly undergoing 
nutritional intervention with a high calorie diet and 
therefore, the development of re-feeding hypo-P is 
not surprising. 
 This study demonstrated a relatively higher 
mean serum phosphate of 0.91mmol/l on admission 
with only 6% of the patients found to have severe 
hypo-P. On follow up, phosphate levels significantly 
dropped with a simultaneous rise in percentage 
of severe hypo-P, peaking after two days. Manary 
et al (13) observed a similar trend where 12% of 
patients developed severe hypo-P within 48 hours 
of nutritional intervention. From our cohort, 22% of 
the patients attained severe levels as early as 48 hours 
and a rise in mean phosphate level was observed on 
day four. 
 Marik et al (17) studied a heterogeneous group 
of 62 intensive care unit adult patients who were 
undernourished and had undergone a period of 
starvation lasting more than 48 hours. They found 
21(34%) of their patients to have developed re-feeding 
hypo-P with a nadir serum phosphate attained after 
about two days. These hypo-phosphataemic patients 
had a longer period of mechanical ventilation and 
hospital stay. In their study, the finding of a nadir 
serum phosphate after two days resembles the 
findings in our cohort and also demonstrates that re-
feeding hypo-P can accompany fairly short periods 
of starvation due to intra-cellular phosphate shifts. 
 Similar trends have been observed in adult 
studies. Weinsier et al (18) reported two adult cases 
with severe malnutrition that developed severe hypo-
P within 48 hours of total parenteral nutrition. Their 
serum phosphate levels similarly showed an upward 
trend on day four. Both patients died soon afterwards 
from complications of the re-feeding syndrome. 
It is believed that re-feeding hypo-P significantly 
contributed to their deaths due to the close temporal 
relationship between declining serum phosphate 
level and their acute cardiac decompensation. In our 
study, 21% (8 of 38) of patients with severe hypo-P 
died. Mortality rates ranging from 63 to 100% have 
been found in patients who developed the re-feeding 
syndrome (l3,18). 
 From this cohort, it was demonstrated that 
there is an increasing mortality with increasing 
severity of nadir serum phosphate level. A similar 
finding has been observed in other studies elsewhere 
(12,13,18). However, the mortality in this cohort may 
be slightly lower and we speculate that this may be 
attributable to the erratic and inadequate supply of 
feeds administered to the children in this setting. This 
scenario of sub-optimal intake of calories tends to 
be inadvertently protective against the effects of the 
re-feeding syndrome. Therefore, in most instances, re-
feeding syndrome is treated by cautious progressive 
nutrition achieved by a reduction in volume and 
caloric density of the feeds (l0,14,19,20).
 In the current study, it was demonstrated that 
a modest proportion of 19% of the deaths occurred 
a day after the mean nadir serum phosphate. The 
deaths on admission could be attributable to the 
initial complications of malnutrition observed on 
admission such as hypoglycaemia, hypothermia, 
and dehydration (7,21). The rest of the mortalities 
are distributed throughout the week. There are no 
similarly designed studies to compare our findings 
with. However, Manary et al (13) attributed five of 
eight (63%) of mortalities to hypo-P in the first 48 hours 
of admission. They only followed up their cohort to 48 
hours after admission. Other reports which comprise 
mainly case studies, have reported mortality to occur 
even later than the first week (10,18). 
 There were a number of limitations to our study. 
Although we explored the demographic, clinical and 
laboratory correlates of hypo-P, the study was not 
designed to answer that question and therefore was 
under-powered to demonstrate clearly the presence 
or absence of associations. Due to logistical reasons, 
the amount of feed prescribed could not be measured 
during the study period. Confounders that may have 
contributed to mortality include hypoglycaemia, 
hypothermia, dehydration and infections. Follow-up 
of patients to discharge was not done as only the first 
week was considered. Therefore, full outcome during 
the admission for every child was not measured. 
 We concluded that the prevalence of hypo-P at 
admission was high at 86%, with 54%, 26% and 6% 
having mild, moderate and severe levels respectively. 
We also concluded that in our study population an 
increase in the prevalence of hypo-P after nutritional 
intervention, rose from 86% at baseline to 90% and 
93% at day one and two respectively, and was still 
high at 89% on day 4. Severe hypo-P prevalence 
similarly rose to 18% and 22% on day one and two 
respectively and dropped to 10% on day four. Our 
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findings demonstrates a positive association between 
severity of nadir hypo-P and mortality, with an 
observed mortality of  0% among children with normal 
nadir phosphate and 8, 14 and 21% among children 
with mild, moderate and severe nadir hypo-P. The 
findings of this study will also inform the formulation 
of future feeding guidelines.
 With such a high prevalence of severe hypo-P, 
and with there being no reliable clinical method 
for identification of this metabolic disturbance, we 
recommend that serum phosphate should at least 
be measured at admission and on day two (13). Our 
findings suggest that there may be value in providing 
routine phosphate supplementation while re-feeding 
severely malnourished children. There is need to 
further evaluate the efficacy and safety of phosphorus 
supplementation in kwashiorkor and marasmic 
kwashiorkor children. Future studies should also 
evaluate the effect of the gradual introduction and 
progression in calories on the reduction of hypo-P. 
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